Jeffrey D. Marrazzo - Feb 29, 2024 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director
Signature
/s/ Karen Brown, attorney-in-fact
Stock symbol
PRME
Transactions as of
Feb 29, 2024
Transactions value $
$0
Form type
4
Date filed
3/4/2024, 09:20 PM
Previous filing
May 12, 2023
Next filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +250K $0.00 250K Feb 29, 2024 Common Stock 250K $8.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in full on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service through such vesting date.